Evolution of chronic lymphocytic leukemia. Predictive value of immunophenotype, sCD23 and morphology;Evolucion de la leucemia linfatica chronica valor predictivo del inmunofenotipo, el CD23 soluble y la morfologia

Medicina

Volumn 62, Issue 4, 2002, Pages 305-312

  Sarmiento, Marcela A ^a   Palacios, Maria Fernanda ^a   Scolnik, Mariano P ^a   Ramirez, Federico R ^a   Stanganelli, Carmen ^a   Cabrera, Juana ^a   Chena, Christian P ^a   Arrossagaray, Guillermo ^a   Slavutsky, Irma R ^a   Bengio, Raquel M ^a  

^a ACADEMIA NACIONAL DE MEDICINA   (Argentina)

Author keywords

Chronic lymphocytic leukemia; Prognosis factors

Indexed keywords

BETA 2 MICROGLOBULIN; CD23 ANTIGEN; TUMOR MARKER; IMMUNOGLOBULIN E RECEPTOR;

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CELL STRUCTURE; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; DEATH; DISEASE ACTIVITY; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; IMMUNOPHENOTYPING; KARYOTYPING; LYMPHOCYTE PROLIFERATION; MALE; PROGNOSIS; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; TRISOMY; BLOOD; CELLULAR IMMUNITY; GENETICS; IMMUNOLOGY; MIDDLE AGED; PATHOLOGY; PREDICTION AND FORECASTING;

ADULT; AGED; AGED, 80 AND OVER; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNITY, CELLULAR; IMMUNOPHENOTYPING; LEUKEMIA, LYMPHOCYTIC, CHRONIC; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; RECEPTORS, IGE;

EID: 0036383722     PISSN: 00257680     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Caligaris-Cappio F, Hamblin TJ. B-cell chronic lymphocytic leukemia: a bird of a different feather. J Clin Oncol 1999; 17: 399-401.
2. Rozman C, Montserrat E. Chronic lymphocytic leukemia. N Engl J Med 1995; 333: 1052-9.
3. Caligaris-Cappio F. B-chronic lymphocytic leukemia: a malignancy of anti-self B cells. Blood 1996; 87: 2615-20.
4. Stavisky K, Bar-Shira A, Gilad S, et al. A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science 1995; 268: 1749-52.
5. Wickremasinghe RG, Hoffbrand AV. Biochemical and genetic control of apoptosis: relevance to normal hematopoiesis and hematological malignancies, Blood 1999; 93: 3587-90.
6. Inghirami G. Differential expression of LFA-1 molecules in non-Hodgkin's lymphoma and lymphoid leukemia. Blood 1988; 72: 1431:4.
7. Medeiros L J. Expression of LFA-1 in non-Hodgkin's lymphoma. Cancer 1989; 63: 255-7.
8. Strauder R. Expression of leukocyte function-associated antigen-1 and 7F7-antigen, an adhesion molecule related to intercellular adhesion molecule-1 (ICAM 1) in non-Hodgkin's lymphomas and leukemias: possible influence on growth patterns and leukemic behavior Clin. Exp. Imm. 1989; 77: 234-7.
9. Maio M. Differential expression of CD54 /intercellular adhesion molecule-1 in myeloid leukemias and in lymphoproliferative disorders. Blood 1990; 76: 783-5.
10. Pals S T. Expression of lymphocyte homing receptor as a mechanism of dissemination in non-Hodgkin's lymphoma. Blood 1989; 73: 885-9.
11. Picker L J. Expression of lymphocyte homing receptor antigen in non-Hodgkin's Lymphomas. Am. J. Pathol 1988; 130: 496-9.
12. Spertini, O. Regulation of leukocyte adhesion molecule-1 expression and shedding by normal and malignant cells. Leukemia 1991; 5: 300-4.
13. Tooze J. Decreased expression of complement receptor type 2 on neoplastic B cells of chronic lymphocytic leukaemia. Clin. Exp. Imm. 1991; 83:423-3.
14. Caligaris-Cappio F. New insight into the biology of B-chronic lymphocytic leukemia. In: American Society of Hematology Education Program Book 1999, p 249-54.
15. Dameshek W. Chronic lymphocytic leukemia -an accumulative disease of immunologically incompetent lymphocytes. Blood 1967; 29: 566-70.
16. Rai KR, Sawitsky A, Cronkite EP et al. Clinical staging of chronic lymphocytic leukemia. Blood 1975; 46: 219-22.
17. Molica S. Prognostic factors in chronic lymphocytic Leukemia. In: Cheson BD (ed). Chronic Lymphoid Leukemias. Second Edition, Revised and Expanded. Marcel Dekker, Inc New York Basel 2001: p 231-60.
18. Criel A, Verhoef G, Vlietinck R, et al. Further characterization of morphologically defined typical and atypical CLL: a clinical, immunophenotypic, cytogenetic and prognostic study on 390 cases. B J Haematol 1997; 97: 383-91.
19. Oscier DG, Matutes E, Copplestone A, et al. Atypical lymphocyte morphology: an adverse prognostic factor for disease progression in stage A CLL independent of trisomy 12. B J Haematol 1997; 98: 934-9.
20. Döhner H, Stilgenbauer S, Benner A, et al. Genomic aberrations and survival in chronic lymphocytic leukemia. N Eng J Med 2000; 343: 1910-6.
21. Keating, M J. The serum beta2-microglobulin level is more powerful than stage in predicting response and survival in chronic lymphocytic leukemia. Blood 1995; 86 (supp 1): 606a.
22. Sarfati M, Chevret S, Chastang C et al. Prognostic importance of serum soluble CD23 level in chronic lymphocytic leukemia. Blood 1996; 88: 4259-64.
23. Beguin Y, Lampertz S, DeGroote D, Igot D, Malaise M, Fellet G. Soluble CD23 and other receptors (CD4, CD8, CD25; CD71) in serum of patients with chronic lymphocytic leukemia. Leukemia 1993; 7: 2019-25.
24. Molica S, Levato D, Dell'Olio M, et. al. Cellular expression and serum circulating levels of CD23 in B-cell chronic lymphocytic leukemia. Implications for prognosis. Haematologica 1996; 81: 428-33.
25. Matutes E, Owusu-Ankomah K, Morilla R, Garcia Marco J, Houlihan A, Que T.H., Catovsky D. The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL. Leukemia 1994; 8: 1640-5.
26. Damble RN, Wasill T, Fais F, et al: Immunoglobulin V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 1999; 94: 1840-3.
27. Hamblin TJ, Davis Z, Gardiner A, Oscier DG, Stevenson FK: Unmutated immunoglobulin VH genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 1999; 94: 1848-51.
28. Chiorazzi N, Ferrarini M. Immunoglobulin variable region gene characteristics and surface membrane phenotype define B-CLL subgroups with distinct clinical courses. In: Cheson BD (ed). Chronic Lymphoid Leukemias. Second Edition, Revised and Expanded. Marcel Dekker, Inc New York Basel 2001: p 81-109.
29. Cheson B, Bennett J, Graver M, Kay N, Keating M, O'Brien S, Rai K: National Cancer Institute-Sponsored Working Group Guidelines for chronic lymphocytic leukemia: Revised Guidelines for Diagnosis and Treatment. Blood 1996; 87: 4990-5.
30. Bennett JM; Catovsky D, Flandrin MT, Galton G, Gralnick DAG, Sultan C. Proposal for the classification of chronic (mature) B and T lymphoid leukaemias. J Clin Phat 1989; 42: 567-70.
31. D'Arena G, Keating M and Carotenuto M. Chronic lymphoproliferative disorders: an integrated point of view for the differential diagnosis. Leukemia and Lymphoma 2000; 36: 225-37.
32. Sarfati M, Bron D, Lagneaux L, Fonteyn C, Frost H, Delespesse G: Elevation of IgE-binding factors in serum of patients with B cell-derived chronic lymphocytic leukemia. Blood 1988; 71: 94-9.
33. Moreau E, Matutes E, A'Hern R, Morilla R, et al. Improvement of the chronic lymphocytic leukemia scoring system with the monoclonal antibody SN8 (CD 79b). Hematopathology 1997; 108: 378-82.
34. Chena C, Sarmiento M, Palacios MF, Scolnik M, Slavutsky I. Dup(12)(q13-q22) and 13q14 deletion in a case of B-cell chronic lymphocytic leukemia. Acta Haematol 2000; 104: 197-201.
35. Geisler Ch, Larsen J, Hansen N, Hansen M, Christensen B, Lund B, at al. Prognostic importance of flow cytometric immunophenotyping of 540 consecutive patients with B-cell chronic lymphocytic leukemia. Blood 1991; 78: 1795-801.
36. Juliusson J, Oscier DG, Fitchett M, et al. Prognostic subgroups in B-cell chronic lymphocytic leukemia defined by specific chromosomal abnormalities. N Engl J Med 1990; 323: 720-5.
37. Oscier DG. Cytogenetic and molecular abnormalities in chronic lymphocytic leukemia Blood Rev 1994; 8: 88-97.
38. Perez-Losada A, Wessman M, Tiainen M et al. Trisomy 12 in chronic lymphocytic leukemia: An interphase cytogenetic study. Blood 1991; 78: 775-9.
39. Anastasi J, Le Beau MM, Vardiman JW, Fernald AA, Larson RA, Rowley JD. Detection of trisomy 12 in chronic lymphocytic leukemia by fluorescence in situ hybridization to interfase cells: A single and sensitive method. Blood 1992; 79: 1796-801.
40. Döhner H, Pohl S, Bulgay-Morschel M, Stilgenbauer S, Bentz M, Lichter P. Trisomy 12 in chronic lymphocytic leukemias - A metaphase and interphase cytogenetic analysis. Leukemia 1993; 7: 516-20.
41. Escudier SM, Pereira-Leahy JM, Drach JW et al. Fluorescent in situ hybridization and cytogenetic studies of trisomy 12 in chronic lymphocytic leukemia. Blood 1993; 81: 2702-7.
42. Stilgenbauer S, Bullinger L, Benner A et al:. Incidence and clinical significance of 6q deletions in B cell chronic lymphocytic leukemia. Leukemia 1999; 13: 131-4.
43. Juliusson G, Oscier D, Gahrton G (IWCCLL). Cytogenetic findings and survival in B-cell chronic lymphocytic leukemia. Second IWCCLL compilation of data on 662 patients. Leukemia & Lymphoma 1991; 5: 21-5.
44. Bird ML, Ueshima Y, Rowley JD, Haren JM, Vardiman JW. Chromosome abnormalities in B-cell chronic lyumphocytic leukemia and their clinical correlations. Leukemia 1989; 3: 182-91.
45. Oscier DG, Stevens J, Hamblin TJ, Pickering RM, Lambert R. Fitchett M. Correlation of chromosome abnormalities with laboratory features and clinical course in B-cell chronic lymphocytic leukemia. B J Haematol 1990; 76: 352-8.